Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Active not recruiting × Lymphedema × Clear all

Phase

Phase NA 9 Phase 3 1

Status

Completed 5 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 110 Carcinoma, Non-Small-Cell Lung 97 Prostatic Neoplasms 56 Multiple Myeloma 46 Neoplasms 35 Neoplasm Metastasis 35 Ovarian Neoplasms 26 Melanoma 24 Urinary Bladder Neoplasms 23 Parkinson Disease 4, Autosomal Dominant Lewy Body 23 Leukemia, Lymphocytic, Chronic, B-Cell 21 Carcinoma, Renal Cell 21 Lung Neoplasms 20 Recurrence 19 Colorectal Neoplasms 19 Leukemia, Myeloid, Acute 18 Carcinoma, Hepatocellular 18 Triple Negative Breast Neoplasms 16 Stomach Neoplasms 15 Lymphoma, Non-Hodgkin 15 Nasopharyngeal Carcinoma 14 Lymphoma 14 Squamous Cell Carcinoma of Head and Neck 13 Lymphoma, Large B-Cell, Diffuse 13 Carcinoma 13 Small Cell Lung Carcinoma 12 Fallopian Tube Neoplasms 12 Colonic Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Uterine Cervical Neoplasms 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04228991 2025-11-18

RHEAL

Ontario Clinical Oncology Group (OCOG)

Phase 3 Active not recruiting

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡